Recent Finacing
Recent Raise
clock.bio uses a proprietary forced‑aging hiPSC model with genome‑wide CRISPR and single‑cell RNA‑seq to map rejuvenation genes, validate targets, and advance drug and gene‑therapy leads.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Clock Bio.